Ultragenyx Pharmaceutical (RARE) Q4 2018 Earnings

5NovConfirmed
Q1 2018
Q2 2018
Q3 2018
Q4 2018
-2.09
-1.68
-1.28
-0.87

Details

Expected EPS
-1.93
Actual EPS
-1.74
Surprise EPS
0.19
Surprise Percent
+9.84%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.74 per share for Q4 2018.

0 Comments

Share your thoughts